e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Cellular responses and cell therapy in lung injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury
S. Rolandsson Enes (Burlington, United States of America), S. C. Abreu (Burlington, United States of America), T. H. Hampton (Hanover, United States of America), R. A Cramer (Hanover, United States of America), B. A. Stanton (Hanover, United States of America), M. Wargo (Burlington, United States of America), D. J Weiss (Burlington, United States of America)
Source:
International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Session:
Cellular responses and cell therapy in lung injury and repair
Session type:
Poster Discussion
Number:
3857
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Rolandsson Enes (Burlington, United States of America), S. C. Abreu (Burlington, United States of America), T. H. Hampton (Hanover, United States of America), R. A Cramer (Hanover, United States of America), B. A. Stanton (Hanover, United States of America), M. Wargo (Burlington, United States of America), D. J Weiss (Burlington, United States of America). Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury. 3857
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The impact of anti-IgE treatment on the airway microbiome in asthma.
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Does IL-13 play a role in acute or resolving lung injury?
Source: Eur Respir J 2001; 18: Suppl. 33, 182s
Year: 2001
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process
Source: Eur Respir J 2004; 24: Suppl. 48, 592s
Year: 2004
Lymphocytes play an essential role in lung ischemia-reperfusion injury
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007
The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 122s
Year: 2003
The role of pro-inflammatory cytokine activation in perioperative lung injury
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004
Novel protective role of alveolar macrophages in adaptation to lung injury.
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
The role of mitochondrial DAMPs in driving lung inflammation and injury
Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Year: 2016
Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Latent TGF-ß binding protein 4 is an important factor that influences anti-inflammatory and cell-protective responses in the pathogenesis of pulmonary emphysema
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020
Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage
Source: Eur Respir J 2003; 22: Suppl. 45, 458s
Year: 2003
Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005
The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Mechanisms of vascular endothelial cell injury in response to intermittent and continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003
The extracellular matrix: the stromal cell niche plays a central role in the quest to induce lung repair in emphysema
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
The role of pre-receptor glucocorticoid metabolism in regulating the severity and persistence of murine lung injury
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
The role of lipoxin A
4
and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept